Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Host / Isotype||Goat / IgG|
|Immunogen||Synthetic peptide sequence (GEKNGDAKTFWME) corresponding to the N-terminus amino acids of SETDB2|
|Purification||Antigen affinity chromatography|
|Storage buffer||TBS, pH 7.3, with 0.5% BSA|
|Contains||0.02% sodium azide|
|Storage Conditions||-20° C, Avoid Freeze/Thaw Cycles|
|Tested Applications||Dilution *|
|Western Blot (WB)||0.3-1 ug/ml|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
This antibody is predicted to react with bovine, canine, mouse, porcine and rat based on sequence homology.
Proteins that contain a SET domain, such as SETDB2, modulate gene expression epigenetically through histone H3 methylation. SETDB2 is likely a histone H3 methyltransferase, as it contains both the active site and flanking cysteine residues required for catalytic activity .
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
C13orf4; chronic lymphocytic leukemia deletion region 8; chronic lymphocytic leukemia deletion region gene 8 protein; CLLD8; CLLL8; CLLL8 protein; DKFZp586I0123; DKFZp761J1217; histone-lysine N-methyltransferase SETDB2; KMT1F; lysine N-methyltransferase 1F; SET domain, bifurcated 2; SETDB2
C13orf4; CLLD8; CLLL8; KMT1F; SETDB2